The company said the data on the drug molnupiravir had been submitted to the U.S. Food and Drug Administration ahead of a meeting of its expert advisers on Tuesday.
Merck’s COVID-19 pill reduces hospitalization, death risk by 30%, company says
© The Crystal Eyes